Rational Use of in Vitro P-glycoprotein Assays in Drug Discovery
- 1 November 2001
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 299 (2) , 620-628
- https://doi.org/10.1016/s0022-3565(24)29270-3
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Influence of Passive Permeability on Apparent P-glycoprotein KineticsPharmaceutical Research, 2000
- P-GLYCOPROTEIN SYSTEM AS A DETERMINANT OF DRUG INTERACTIONS: THE CASE OF DIGOXIN–VERAPAMILPharmacological Research, 1999
- Structure–activity relationship studies of propafenone analogs based on P-glycoprotein ATPase activity measurementsBiochemical Pharmacology, 1999
- P-Glycoprotein, a gatekeeper in the blood–brain barrierAdvanced Drug Delivery Reviews, 1999
- Role of P-Glycoprotein on the CNS Disposition of Amprenavir (141W94), an HIV Protease InhibitorPharmaceutical Research, 1999
- The P-Glycoprotein Efflux Pump: How Does it Transport Drugs?The Journal of Membrane Biology, 1997
- Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activityPublished by Elsevier ,1997
- Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*Clinical Pharmacology & Therapeutics, 1997
- Drug-stimulated ATPase activity of the human P-glycoproteinJournal of Bioenergetics and Biomembranes, 1995
- Microfluorometric Evaluation of Calcein Acetoxymethyl Ester as a Probe for P-Glycoprotein-Mediated Resistance: Effects of Cyclosporin A and Its Nonimmunosuppressive Analogue SDZ PSC 833Experimental Cell Research, 1994